ERBB2 and breast cancer: Table 1 summarizes the key findings from the selected studies, including the authors, year of publication, breast cancer type, anthracycline used, concomitant anti-Human Epidermal Growth Factor Receptor 2 (HER2) therapy and/or radiotherapy, sample size, gender distribution, and the main LV echocardiographic parameters.